-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs025984-malone-final-report-2023.pdf
January 01, 2023 - We extracted the list of drugs in each interacting group and variables that can affect the risk or … Controls consisted of
patients receiving other disease modifying rheumatic drugs. … Of the 23-drug average per group, an average of 3.8 drugs
per group were the same across references. … Drug interactions involving drugs used to treat COVID-19 (date 5/13/2020)
10. … Drugs Real World Outcomes. 2022
Sep;9(3):415-423. doi: 10.1007/s40801-022-00307-5.
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/poster-2014
January 01, 2014 - An International Evaluation of User Perceptions of Drug-Drug and Drug-Allergy Interaction Alerts
Citation
Robertson A, Neri P, Burdick E, et al. An International Evaluation of User Perceptions of Drug-Drug and Drug-Allergy Interaction Alerts. American Medical Informatics Association (AMIA) 2014 Annual…
-
digital.ahrq.gov/ahrq-funded-projects/electronic-prescribing-and-electronic-transmission-discharge-medication-lists/annual-summary/2011
January 01, 2011 - Cardiovascular drugs, gastrointestinal drugs, non-narcotic analgesics, and anti-coagulants were the classes
-
digital.ahrq.gov/ahrq-funded-projects/personal-health-records-and-elder-medication-use-quality/annual-summary/2011
January 01, 2011 - group (8.9 percent versus 13.2 percent), and to be taking two or more nonsteroidal anti-inflammatory drugs … The most frequent PHR-generated medication warnings were for nonsteroidal anti-inflammatory drugs, angiotensin
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs024945-lambert-final-report-2022.pdf
January 01, 2022 - ); (2) all initiated orders for study drugs; and (3) all initiated orders
for study drugs that were … Since only a
subset of all medication orders are study drugs, and alerts did not fire on non-study drugs … The list of study drugs was limited to those that had only a few,
well-defined indications and that … the health systems deemed to be useful, resulting in n=206 study drugs at NM
and n=87 at Columbia/NYP … The results reported here may not generalize to other drugs, especially to those
with many indications
-
digital.ahrq.gov/ahrq-funded-projects/enabling-shared-decision-making-reduce-harm-drug-interactions-end-end/citation/shared-decision
January 01, 2023 - Shared decision-making for drug-drug interactions: Formative evaluation of an anticoagulant drug interaction.
Citation
Gomez Lumbreras A, Reese TJ, Del Fiol G, Tan MS, Butler JM, Hurwitz JT, Brown M, Kawamoto K, Thiess H, Wright M, Malone DC. Shared decision-making for drug-drug interactions: Formativ…
-
digital.ahrq.gov/ahrq-funded-projects/centers-medicare-medicaid-services-special-study-%E2%80%93-pilot-testing-electronic
January 01, 2023 - However, when ePA was expanded to additional drugs and health plans, substantial work on the part of
-
digital.ahrq.gov/sites/default/files/docs/resource/final-b14-archives-sarkar2075.pdf
January 01, 2013 - Patient is/is not taking any
anticoagulant drugs (i.e., Coumadin, heparin) or antiplatelet drugs (i.e … Patient may/may not stop these drugs 7 days prior to
procedure.”
xvi. … Patient is/is not taking any
anticoagulant drugs (i.e., Coumadin, heparin) or antiplatelet drugs (i.e … Patient may/may not stop these drugs 7 days prior to
procedure.”
xvi.
-
digital.ahrq.gov/sites/default/files/docs/page/Root.ppt
June 01, 2005 - November 15-18, 2004
Physician to Hospital
Medical necessity; Admissions; pre-natal reports
current drugs … nec; Workers Comp notes; P4P
Claims; claim status; eligibility, prior auths
Formularies, current drugs … eligibility, prior authorizations
Drug look-ups Case reporting;
RODS
Vital records
Tumor registries Drugs … E-prescriptions; Questions about tests and results
Health Plans Pharmacy eligibility, formularies, current drugs
-
digital.ahrq.gov/ahrq-funded-projects/partnering-improve-patient-safety-rural-wv
January 01, 2023 - Regional Medical Center, agreed to participate in a pilot project that would record the use of "rescue drugs … pharmacy every two weeks produced a list of patients who received one of eight commonly used rescue drugs
-
digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-transcript-081811.pdf
June 16, 2021 - For some drugs it wasn’t the dose that was the issue, it was the frequency with which
drugs were being … The third set of recommendations were for drugs which at particularly low levels of renal
insufficiency … were quite a few attempts during the course
of the year that we tracked to actually try to order drugs … taking; recommendations about dosing
issues; and recommendations about lab monitoring of the new drugs … And that’s a dangerous assumption
because then why would you tell your physician about your drugs taken
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-nursing-home/annual-summary/2008
January 01, 2008 - Sixty-two drugs were selected for inclusion based on published guidelines and lists from hospital-based … dosing alert systems; those chosen included oral drugs commonly prescribed in the long-term care setting
-
digital.ahrq.gov/ahrq-funded-projects/e-prescribing-impact-patient-safety-use-and-cost/annual-summary/2009
January 01, 2009 - E-prescriptions in the intervention group showed a 6.6 percent increase in the proportion of Tier 1 drugs … The proportion of drugs in Tier 2 and Tier 3 (brand-name medications) decreased correspondingly.
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015413-samore-final-report-2008.pdf
January 01, 2008 - Although it is possible to
create orders for custom formulations or usage instructions for drugs, generally … We defined warfarin, lovastatin/simvastatin, and methylphenidate/adderall as object drugs of
interest … Precipitant drugs and their potential consequences
Object Drug Precipitant Drug
Anticipated Change … A mean of 70 patients per clinic had
17
received one or more of the target drugs. … New prescriptions for familiar drugs and controlled substances took longer
with the CCOE tool.
-
digital.ahrq.gov/sites/default/files/docs/page/2006RaynerGorman_051911comp.pdf
June 16, 2021 - • RxNorm
• part of UMLS Metathesaurus
• designated as nomenclature standard for clinical drugs
•
-
digital.ahrq.gov/sites/default/files/docs/citation/u18hs027557-dykes-final-report-2022.pdf
January 01, 2022 - project team identified three fall injury risk factors (mobility limitations, fall risk
increasing drugs … Recommendations were grouped by risk factor
with exercise first, fall risk increasing drugs (FRIDS) … In the medication section all recommendations
were based on the class of medication the drugs selected … FRIDS tailored
deprescription resources
N/A because
deprescribing
was not used
0 some drugs
did … /primary-care-management-guidance-fall-risk-
increasing-drugs
Bibliography:
1.
-
digital.ahrq.gov/2019-year-review/research-summary/emerging-innovative-newly-funded-research/creating-age-friendly-health-systems-implementing-decision
January 01, 2019 - Some drugs are not as effective or have adverse risks for older adults, but some providers do not know
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/gilmet-gp-et-al-1998
January 01, 1998 - records on members 18 years of age and older that included prescription claims for diabetes-specific drugs
-
digital.ahrq.gov/ahrq-funded-projects/value-new-drug-labeling-knowledge-e-prescribing/annual-summary/2008
January 01, 2008 - vendor and product-centric labels; while SPL labels still cover only 23 percent of RxNorm clinical drugs … This is shown best by the ability to use the SPL labels and their descriptions of drugs directly for
-
digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/designing
January 01, 2023 - Designing and evaluating contextualized drug-drug interaction algorithms.
Citation
Chou E, Boyce RD, Balkan B, Subbian V, Romero A, Hansten PD, Horn JR, Gephart S, Malone DC. Designing and evaluating contextualized drug-drug interaction algorithms. JAMIA Open. 2021 Mar 19;4(1):ooab023. doi: 10.1093/j…